Hyfe的封面图片
Hyfe

Hyfe

医院和医疗保健

Wilmington,Delaware 3,145 位关注者

AI-powered cough-tracking & insights. Precision medicine for respiratory health

关于我们

Hyfe is the global leader in cough. Our longitudinal cough monitoring and insights capabilities are used daily by thousands of researchers, pharma, physicians and patients across the world. From remote-patient-monitoring in chronic care management, to digital biomarkers for clinical trials, we bring precision medicine and personalized approaches to respiratory health. Hyfe’s AI models are trained on the world's largest database of 25B+ data points collected from 160+ countries. Hyfe has also been validated in 46+ research trials across indications including asthma, COPD, Congestive Heart Failure and Covid.

网站
https://www.hyfe.com/
所属行业
医院和医疗保健
规模
11-50 人
总部
Wilmington,Delaware
类型
私人持股
创立
2020
领域
Healthcare、Wellness和AI

地点

Hyfe员工

动态

  • Hyfe转发了

    查看Julian Circo的档案

    Co-Founder @ Hyfe | AI Powered Cough Monitoring | Pioneering the world's first Digital Therapeutic (DTx) for Cough

    Almost 40% of all Americans suffer from a respiratory condition. That's more than 130 million people. Chances are these numbers will even trend higher ion others parts of the world where things like air quality or smoking would add additional risks. Every single one of them is coughing. And yet, in our clinical standards we have normalized the fallacy that somehow we don't need to quantify this incredibly common and critical symptom. It makes sense. People's subjective perception of their own coughing is unreliable. And using "gold standard" methods to quantify cough - sound recorders that record everything - has been seriously impractical. This is a problem that Hyfe has solved. It is now not only possible but in fact easy and convenient to measure cough in pretty much any setting. There is even a free app that anyone can use to do just that. (Image source: Pleasants RA, Heidari K, Ohar J, Donohue JF, Lugogo NL, Kanotra SM, Kraft M, Mannino DM, Strange CB. Respiratory Symptoms among US Adults: a Cross-Sectional Health Survey Study. Pulm Ther. 2022 Sep;8(3):255-268. doi: 10.1007/s41030-022-00194-9. Epub 2022 Jul 6. PMID: 35794458; PMCID: PMC9458821).

    • 该图片无替代文字
  • 查看Hyfe的组织主页

    3,145 位关注者

    We're #hiring! ??fully remote ???? fluent in Japanese Hyfe has commenced an exciting multi-year partnership with a pharma company to develop and commercialize the world’s first digital therapeutic (DTx). We are seeking a Product Manager to drive the ongoing development of the respiratory health DTx app for the Japanese market. This individual will work cross-functionally with the design team, clinical experts, engineers, and the regulatory team to build an engaging, clinically validated, and user-friendly product, that will be available for prescription in Japan. You can find the details and apply below ???? https://lnkd.in/dT6PyJhx

  • 查看Hyfe的组织主页

    3,145 位关注者

    Thank you to MediaPost for highlighting our partnership with KYORIN Pharmaceutical Co., Ltd. and the digital therapeutics we're developing. In the article, Pharma & Health Insider asks: How does behavioral cough suppression therapy (BCST) work? Our Chief Experience Officer Reid Moorsmith explains: ????? ???? ?? ???????? ????????-?????????????????? ???????????????????? ?????????????? ?????????????????? ??????????????????, ?????????? ?????????????????????? ???????????????????? ?????? ???????????????? ???????? ?????????????? ???????????? ?????? ???????? ???????????????????? ?????????????? ?????????? ???? ?????????? ???? ?????????????? ??????????. ??????????????????????????, ????’?? ???????? ?????????????? ???? ?????????? 200 ???????????? ???????????????? ????????????????????????. ?????? ???????? ?????? ????. Slovarp Laurie , ??????’?? ?????? ???? ?????? ??????????’?? ?????????????? ?????????????? ???? ????????. ???? ???????? ???? ?????? ???????? ?????????????? ???? ?????? ???????? ???? ???? ?????? ???? ???????? ???? ???????????? ????????????????????. Read more in the full article: ?? https://lnkd.in/d52yAz_b

  • 查看Hyfe的组织主页

    3,145 位关注者

    Is your wearable device missing a key health indicator? Heart rate, sleep quality, and oxygen levels are common metrics - but what about cough? Hyfe's new whitepaper explores how continuous cough tracking can transform health outcomes by: - Predicting exacerbations - Improving chronic disease management - Unlocking deeper insights for clinical trials and remote patient monitoring Tap into the full potential of wearable health data. ?? Find the link in the comments below

    • 该图片无替代文字
  • Hyfe转发了

    查看Bertalan Meskó, MD, PhD的档案
    Bertalan Meskó, MD, PhD Bertalan Meskó, MD, PhD是领英影响力人物

    The Medical Futurist, Author of Your Map to the Future, Global Keynote Speaker, and Futurist Researcher

    How do you bring digital therapeutics to the market? I discussed it with the Chief Medical Officer of Hyfe, Dr. Peter Small. The full interview is available on our exclusive Patreon channel: https://lnkd.in/evGbFx4p ??. ?????? ???? ?????? ?????????????? ???????????????????????? ???????????? ?????? ?? ?????????????? ??????????????????????? - Assessing DTx/SaMD requirements from regulators based on past experience - Clinical trials to demonstrate safety, efficacy, and cost-effectiveness - Compliance with relevant software-as-a-medical-device (SaMD) regulations, and data privacy and security requirements, which are evaluated as part of the SaMD review -? Regulatory clearance or approval from bodies like the FDA in the US, EMA in EU, PMDA in Japan -? Peer-reviewed dissemination / real-world evidence to reinforce clinical credibility and facilitate reimbursement pathways -? Working with KOLs to establish new clinical standards - Educating and training clinicians working with chronic cough patients, so they can properly prescribe the DTx

    • 该图片无替代文字
  • 查看Hyfe的组织主页

    3,145 位关注者

    What’s it like working at Hyfe? Just ask Stephanie Swift! At Hyfe, we don’t believe in the typical 9-to-5. Every day is different, and flexibility isn’t just a perk - it’s how we work. ???? Steph, our Research Operations Manager, brings years of experience managing clinical trials, leading research projects, and collaborating with global teams. From overseeing vaccine trials with thousands of participants to co-founding a research community of 80+ clinicians, she knows how to make an impact - no matter where she’s working from. Steph shared with us what Life at Hyfe looks like for her ?? ?? Work from anywhere, literally – from research meetings to operational logistics, Steph has even worked from Ottawa's frozen canal, the world’s longest ice rink! ???? ?? Flexibility that fits your life – Whether it’s learning French, skiing, or visiting family in another country, remote work at Hyfe means life comes first. ?? A culture that values ideas – Steph’s advice for new hires? “Don’t be afraid to share ideas, thoughts, and solutions.” We’re all about collaboration and innovation. ?? Dream office? Anywhere with a big screen! (And maybe Valencia, Spain ????) Sounds like your kind of workplace? We’re growing! Check out our open roles ???? and join us in redefining how (and where) work happens. #LifeAtHyfe #RemoteWork #Hiring #FlexibleWork #WorkFromAnywhere

  • 查看Hyfe的组织主页

    3,145 位关注者

    We’re thrilled to be featured in STAT by Mario Aguilar, highlighting our partnership with KYORIN Pharmaceutical Co., Ltd. to develop a digital therapeutic for chronic cough! Japan is just the beginning. As we develop this solution with Kyorin, we're exploring opportunities to bring the DTx to the US and other markets - expanding access to millions who suffer from chronic cough. A big thank you to STAT and Mario for covering this important milestone. We’re excited about the future of digital respiratory therapeutics! ?? Read the full feature here: https://lnkd.in/ddHMhJ44

    • 该图片无替代文字
  • 查看Hyfe的组织主页

    3,145 位关注者

    We appreciate the mention! We're proud to be working with KYORIN Pharmaceutical Co., Ltd. to bring a new option for chronic cough patients in Japan. Digital therapeutics are opening up new possibilities in respiratory care, and we’re glad to be part of the movement!

    查看Gary Monk的档案
    Gary Monk Gary Monk是领英影响力人物

    LinkedIn ‘Top Voice’ >> Follow for the Latest Trends, Insights, and Expert Analysis in Digital Health & AI

    The Pharma Five: February’s Leading Digital Health Collaborations >> ??Shionogi & Co., Ltd secured Japanese approval for the ADHD digital therapeutic EndeavorRide, licensed from Akili targeting a market with limited access to stimulant medications and aiming to integrate digital tools with its broader healthcare-as-a-service model. ??Merck’s international arm, MSD made its first Asia Pacific health tech investment by backing Thailand-based HD, whose online marketplace connects users with healthcare providers, leverages AI for customer interactions, and is already a key channel for MSD’s HPV vaccine sales in Southeast Asia ??Novartis and Dawn Health launch Cora BC, a breast cancer support app enhancing patient tracking, adherence, and communication with healthcare teams. Rolling out first in Germany, it will expand globally, building on their past digital health collaborations. ??Daewoong Pharmaceutical and Seers secure Korea’s first insurance reimbursement for thynC, an AI-powered remote monitoring system with wearable biosensors, enhancing patient safety and hospital efficiency ??Hyfe partners with KYORIN Pharmaceutical Co., Ltd. to launch the world's first prescription digital therapeutic (DTx) for chronic cough in Japan, leveraging AI-powered cough monitoring and Behavioral Cough Suppression Therapy (BCST) with higher efficacy than conventional medications ??Links to relevant articles in comments #DigitalHealth #DTx #Pharma

    • 该图片无替代文字

相似主页

查看职位

融资